The DOI matches its Crossref record; 62 of the 64 references it cites were found in a registry or an index.
Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice
Open accessAbstract
In order to investigate the role of mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 (mtGPAT1) in the pathogenesis of hepatic steatosis and hepatic insulin resistance, we examined whole-body insulin action in awake mtGPAT1 knockout (mtGPAT1(-/-)) and wild-type (wt) mice after regular control diet or three weeks of high-fat feeding. In contrast to high-fat-fed wt mice, mtGPAT1(-/-) mice displayed markedly lower hepatic triacylglycerol and diacylglycerol concentrations and were protected from hepatic insulin resistance possibly due to a lower diacylglycerol-mediated PKC activation. Hepatic acyl-CoA has previously been implicated in the pathogenesis of insulin resistance. Surprisingly, compared to wt mice, mtGPAT1(-/-) mice exhibited increased hepatic insulin sensitivity despite an almost 2-fold elevation in hepatic acyl-CoA content. These data suggest that mtGPAT1 might serve as a novel target for treatment of hepatic steatosis and hepatic insulin resistance and that long chain acyl-CoA's do not mediate fat-induced hepatic insulin resistance in this model.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“recent studies have demonstrated that NAFLD-induced hepatic insulin resistance is a major factor responsible for the transition from normoglycemia to fasting hyperglycemia and T2DM (18–23).”
From The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome (2007) · cites this paper as [22]
In the citing paper
“NAFLD is strongly linked to hepatic insulin resistance”
From The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome (2007) · cites this paper as [22]
In the citing paper
“In this setting, PKCε, but not other isoforms of PKC, is activated.”
From Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease (2007) · cites this paper as [7]
In the citing paper
“An alternate hypothesis is that the development of hepatic steatosis per se causes hepatic insulin resistance.”
From Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease (2007) · cites this paper as [7]
In the citing paper
“Preventing fat accumulation in rodents preserves hepatic insulin action (7,10,12).”
From Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease (2007) · cites this paper as [7]
In the citing paper
“Preventing fat accumulation by inhibiting lipid synthesis via disruption of the mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase (7) or promoting fat oxidation using either the mitochondrial uncoupler 2,4-dinitrophenol (10) or inhibition of acetyl-CoA carboxylase-1 and -2 (12) prevents PKCε activation and hepatic insulin resistance.”
From Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease (2007) · cites this paper as [7]
In the citing paper
“This is important since DAG is a known activator of classic and novel isoforms of PKC and DAG concentrations have closely paralleled insulin resistance in other models (7,12).”
From Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease (2007) · cites this paper as [7]
In the citing paper
“This is important since DAG is a known activator of classic and novel isoforms of PKC and DAG concentrations have closely paralleled insulin resistance in other models (7,12).”
From Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease (2007) · cites this paper as [7]
In the citing paper
“There is increasing evidence for a causal relationship between hepatic steatosis and hepatic insulin resistance both in rodent models with hepatic steatosis and in patients with nonalcoholic fatty liver disease (4, 18-25).”
From Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men (2006) · cites this paper as [22]
Citations
Cites
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Self-citationImpaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Self-citationForman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli‐Labate, A. M., Bianchi, G. P., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,570
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561
Self-citationMechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Self-citationGriffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Self-citationKrssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S. M., Rothman, D. L., Shulman, G. I., & Roden, M. (1999) · Diabetologia · doi:10.1007/s001250051123 · Cited by 1,264
Self-citationEnzymes of triacylglycerol synthesis and their regulation
Coleman, R. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00051-1 · Cited by 985
Self-citationPetersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911
Self-citation
Flagged first, then by citations
2 of the 64 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 260
Sachithanandan, N., Fam, B. C., Fynch, S., Dzamko, N. L., Watt, M. J., Wormald, S., Honeyman, J. E., Galić, S., Proietto, J., Andrikopoulos, S., et al. (2010) · Hepatology · doi:10.1002/hep.23861 · Cited by 107
Galbo, T., Perry, R. J., Jurczak, M. J., Camporez, J. P., Alves, T. C., Kahn, M., Guigni, B. A., Serr, J., Zhang, D., Bhanot, S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311176110 · Cited by 103
Self-citationColeman, R. (2019) · Journal of Lipid Research · doi:10.1194/jlr.s091843 · Cited by 98
Self-citationGlycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling
Zhang, C., Wendel, A. A., Keogh, M. R., Harris, T. E., Chen, J., & Coleman, R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110730109 · Cited by 102
Self-citationKursawe, R., Caprio, S., Giannini, C., Narayan, D., Lin, A., D’Adamo, E., Shaw, M. M., Pierpont, B. M., Cushman, S. W., & Shulman, G. I. (2012) · Diabetes · doi:10.2337/db12-0889 · Cited by 109
Self-citationSpecific protein kinase C isoforms as transducers and modulators of insulin signaling
SAMPSON, S., & COOPER, D. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.04.017 · Cited by 97
Lee, J., & Ridgway, N. D. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.03.010 · Cited by 95
Monsénégo, J., Mansouri, A., Akkaoui, M., Lenoir, V., Esnous, C., Fauveau, V., Tavernier, V., Girard, J., & Prip-Buus, C. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.008 · Cited by 91
Butler, J. A., Hagen, T. M., & Moreau, R. F. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.01.024 · Cited by 93
Fayyaz, S., Henkel, J., Japtok, L., Krämer, S., Damm, G., Seehofer, D., Püschel, G. P., & Kleuser, B. (2013) · Diabetologia · doi:10.1007/s00125-013-3123-6 · Cited by 94
D'souza, A. M., Beaudry, J. L., Szigiato, A.-A., Trumble, S. J., Snook, L. A., Bonen, A., Giacca, A., & Riddell, M. C. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00378.2011 · Cited by 91
Hwang, S., Jeong, Y., Li, X., Kim, Y. D., Lu, Y., Chang, Y., Lee, I., & Chang, H. W. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12124 · Cited by 92
Kumashiro, N., Yoshimura, T., Cantley, J. L., Majumdar, S. K., Guebre‐Egziabher, F., Kursawe, R., Vatner, D. F., Fat, I., Kahn, M., Erion, D. M., et al. (2012) · Hepatology · doi:10.1002/hep.26170 · Cited by 89
Self-citationPetersen, K. F., & Shulman, G. I. (2006) · Obesity · doi:10.1038/oby.2006.280 · Cited by 87
Self-citationTherapeutic opportunities for the treatment of NASH with genetically validated targets
Lindén, D., & Romeo, S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.05.007 · Cited by 86
Villena, J. A., Choi, C. S., Wang, Y., Kim, S., Hwang, Y.-J., Kim, Y., Cline, G. W., Shulman, G. I., & Sul, H. S. (2008) · Diabetes · doi:10.2337/db07-1739 · Cited by 86
Self-citationMolecular mechanisms involved in hepatic steatosis and insulin resistance
Matsuzaka, T., & Shimano, H. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00111.x · Cited by 94
Effects of Pioglitazone on Intramyocellular Fat Metabolism in Patients with Type 2 Diabetes Mellitus
Bajaj, M. S., Baig, R., Suraamornkul, S., Hardies, L. J., Coletta, D. K., Cline, G. W., Monroy, A., Koul, S., Sriwijitkamol, A., Musi, N., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0911 · Cited by 86
Self-citationZhang, D., Christianson, J., Liu, Z., Tian, L., Choi, C. S., Neschen, S., Dong, J., Wood, P. A., & Shulman, G. I. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.012 · Cited by 84
Self-citationWang, S., Lee, D. P., Gong, N., Schwerbrock, N. M. J., Mashek, D. G., González-Baró, M. R., Stapleton, C. M., Li, L. O., Lewin, T. M., & Coleman, R. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.06.033 · Cited by 84
Self-citationIrp2 regulates insulin production through iron-mediated Cdkal1-catalyzed tRNA modification
Ferreira, M. C., Anderson, C. P., Neschen, S., Zumbrennen‐Bullough, K. B., Romney, S. J., Kahle, M., Rathkolb, B., Gailus‐Durner, V., Fuchs, H., Wolf, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14004-5 · Cited by 85
Self-citationWolfgang, M. J., & Lane, M. D. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.25.050304.092532 · Cited by 85
Videla, L. A., & Pettinelli, P. (2012) · PPAR Research · doi:10.1155/2012/107434 · Cited by 79
Goedeke, L., Perry, R. J., & Shulman, G. I. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104727 · Cited by 76
Self-citationPathophysiology of NASH in endocrine diseases
Gariani, K., & Jornayvaz, F. R. (2021) · Endocrine Connections · doi:10.1530/ec-20-0490 · Cited by 77
Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
Zhang, B., Yin, F., Qiao, Y.-N., & Guo, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.909151 · Cited by 83
Early Hepatic Insulin Resistance in Mice: A Metabolomics Analysis
Li, L. O., Hu, Y.-F., Wang, L. H.-C., Mitchell, M. W., Berger, A., & Coleman, R. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0152 · Cited by 74
Self-citationMetabolic and oxidative stress markers in Wistar rats after 2 months on a high-fat diet
Auberval, N., Dal-Ros, S., Bietiger, W., Pinget, M., Jeandidier, N., Maillard-Pedracini, E., Schini‐Kerth, V. B., & Sigrist, S. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-130 · Cited by 72
Insulin Resistance, Obesity, and Lipotoxicity
Yazıcı, D., Demir, S. Ç., & Sezer, H. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_14 · Cited by 85
Hall, A. M., Soufi, N., Chambers, K. T., Chen, Z., Schweitzer, G. G., McCommis, K. S., Erion, D. M., Graham, M. J., Su, X., & Finck, B. N. (2014) · Diabetes · doi:10.2337/db13-1502 · Cited by 68
Stewart, L. K., Wang, Z., Ribnicky, D., Soileau, J. L., Cefalu, W. T., & Gettys, T. W. (2009) · Diabetologia · doi:10.1007/s00125-008-1252-0 · Cited by 71
Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes
Saberi, M., Bjelica, D., Schenk, S., Imamura, T., Bandyopadhyay, G. K., Li, P., Jadhar, V., Vargeese, C., Wang, W., Bowman, K., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00158.2009 · Cited by 66
Liver X Receptor: an oxysterol sensor and a major player in the control of lipogenesis
Ducheix, S., Lobaccaro, J. A., Martin, P. G. P., & Guillou, H. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.06.004 · Cited by 71
Lipotoxic disruption of NHE1 interaction with PI(4,5)P2 expedites proximal tubule apoptosis
Khan, S., Jawdeh, B. G. A., Goel, M., Schilling, W. P., Parker, M. D., Puchowicz, M. A., Yadav, S. P., Harris, R. C., El‐Meanawy, A., Hoshi, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71863 · Cited by 64
A role for phosphatidylcholine and phosphatidylethanolamine in hepatic insulin signaling
van der Veen, J. N., Lingrell, S., McCloskey, N. S., LeBlond, N. D., Galleguillos, D., Zhao, Y., Curtis, J. M., Sipione, S., Fullerton, M. D., Vance, D. E., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802117r · Cited by 65
Phillips, C. M., Goumidi, L., Bertrais, S., Field, M. R., Cupples, L. A., Ordovás, J. M., Defoort, C., Lovegrove, J. A., Drevon, C. A., Gibney, M. J., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003046 · Cited by 67
Hepatic knockdown of mitochondrial GPAT1 in ob/ob mice improves metabolic profile
Xu, H., Wilcox, D. M., Nguyen, P., Voorbach, M. J., Suhar, T., Morgan, S. J., An, W., Ge, L., Green, J., Wu, Z., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.071 · Cited by 64
Wendel, A. A., Li, L. O., Li, Y., Cline, G. W., Shulman, G. I., & Coleman, R. A. (2010) · Diabetes · doi:10.2337/db09-1380 · Cited by 63
Self-citationLian, J., Wei, E., Wang, S. P., Quiroga, A. D., Li, L., Pardo, A. D., van der Veen, J., Sipione, S., Mitchell, G. A., & Lehner, R. S. (2012) · Hepatology · doi:10.1002/hep.25881 · Cited by 64
Divergent Role of Sphingosine 1-Phosphate on Insulin Resistance
Fayyaz, S., Japtok, L., & Kleuser, B. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000362990 · Cited by 62
Lewin, T. M., de Jong, H., Schwerbrock, N. M. J., Hammond, L. E., Watkins, S. M., Combs, T. P., & Coleman, R. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.05.001 · Cited by 60
Self-citationLipid mediators of liver injury in nonalcoholic fatty liver disease
Liangpunsakul, S., & Chalasani, N. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00170.2018 · Cited by 60
Neschen, S., Katterle, Y., Richter, J., Augustin, R., Scherneck, S., Mirhashemi, F., Schürmann, A., Joost, H.-G., & Klaus, S. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00226.2007 · Cited by 58
Self-citationHigh‐throughput Screening of Mouse Knockout Lines Identifies True Lean and Obese Phenotypes
Brommage, R., Desai, U., Revelli, J., Donoviel, D. B., Fontenot, G. K., DaCosta, C. M., Smith, D. D., Kirkpatrick, L., Coker, K. J., Donoviel, M. S., et al. (2008) · Obesity · doi:10.1038/oby.2008.361 · Cited by 59
Mitochondria‐type GPAT is required for mitochondrial fusion
Ohba, Y., Sakuragi, T., Kage‐Nakadai, E., Tomioka, N. H., Kono, N., Imae, R., Inoue, A., Aoki, J., Ishihara, N., Inoué, T., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.77 · Cited by 62
Nonalcoholic fatty liver disease and lipids
Wierzbicki, A. S., & Oben, J. A. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283541cfc · Cited by 57
Insulin Resistance and Vulnerability to Cardiac Ischemia
Jeleník, T., Flögel, U., Álvarez-Hernández, E., Scheiber, D., Zweck, E., Ding, Z., Rothe, M., Mastrototaro, L., Kohlhaas, V., Kotzka, J., et al. (2018) · Diabetes · doi:10.2337/db18-0449 · Cited by 58
Cao, J., Perez, S., Goodwin, B. J., Lin, Q., Peng, H., Qadri, A., Zhou, Y., Clark, R. W., Perreault, M., Tobin, J. F., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00666.2013 · Cited by 56
Jeleník, T., Séquaris, G., Kaul, K., Ouwens, D. M., Phielix, E., Kotzka, J., Knebel, B., Weiß, J., Reinbeck, A. L., Janke, L., et al. (2014) · Diabetes · doi:10.2337/db13-1794 · Cited by 58
Self-citationLipid signals and insulin resistance
Zhang, C., Klett, E. L., & Coleman, R. (2013) · Clinical Lipidology · doi:10.2217/clp.13.67 · Cited by 58
Self-citationGao, X., Chen, T., Zhou, F., Sun, Y., Zhang, J., Li, X., Zhao, W., Li, Y., Shi, Y., Niu, K., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02758-w · Cited by 55
Transcriptional Regulation of Acyl-CoA:Glycerol-sn-3-Phosphate Acyltransferases
Karasawa, K., Tanigawa, K., Harada, A., & Yamashita, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040964 · Cited by 52
Mitochondria mediated cell death in diabetes
Szabadkai, G., & Duchen, M. R. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0363-5 · Cited by 54
Clément, S., Pascarella, S., & Negro, F. (2009) · Viruses · doi:10.3390/v1020126 · Cited by 52
Guo, H., Li, D., Ling, W., Feng, X., & Xia, M. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m013375 · Cited by 52
Rong, X., Li, Y., Ebihara, K., Zhao, M., Naowaboot, J., Kusakabe, T., Kuwahara, K., Murray, M. T., & Nakao, K. (2010) · Diabetologia · doi:10.1007/s00125-010-1744-6 · Cited by 51
Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease
Kleuser, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030722 · Cited by 54
Kahle, M., Schäfer, A., Seelig, A., Schultheiß, J., Wu, M., Aichler, M., Leonhardt, J., Rathkolb, B., Rozman, J., Sarioglu, H., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.11.004 · Cited by 47
Self-citationMultiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis
Zhang, X., She, Z., Wang, J., Sun, D., Shen, L., Xiang, H., Cheng, X., Ji, Y., Huang, Y., Li, P., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abg8117 · Cited by 49
Self-citationHenriksen, B. S., Curtis, M. E., Fillmore, N., Cardon, B. R., Thomson, D. M., & Hancock, C. R. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-29 · Cited by 49
Tumor Progression Locus 2 (TPL2) Regulates Obesity-Associated Inflammation and Insulin Resistance
Perfield, J. W., Lee, Y., Shulman, G. I., Samuel, V. T., Jurczak, M. J., Chang, E., Xie, C., Tsichlis, P. N., Obin, M. S., & Greenberg, A. S. (2011) · Diabetes · doi:10.2337/db10-0715 · Cited by 52
Self-citationDoes Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?
Finck, B. N., & Hall, A. M. (2015) · BioMed Research International · doi:10.1155/2015/104132 · Cited by 47
Deng, W., Wang, X., Xiao, J., Chen, K., Zhou, H., She, Z., Li, H., & Tang, Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030256 · Cited by 47
Alves, T. C., Befroy, D. E., Kibbey, R. G., Kahn, M., Codella, R., Carvalho, R. A., Petersen, K. F., & Shulman, G. I. (2011) · Hepatology · doi:10.1002/hep.24170 · Cited by 47
Self-citationFernyhough, P., & McGavock, J. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00027-8 · Cited by 50
Kuhajda, F. P., Aja, S. M., Tu, Y., Han, W. F., Medghalchi, S. M., Meskini, R. E., Landree, L. E., Peterson, J. M., Daniels, K., Wong, K., et al. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00147.2011 · Cited by 45
Jia, Y., Yee, J. K., Wang, C., Nikolaenko, L., Diaz‐Arjonilla, M., Cohen, J. N., French, S. W., Liu, P. Y., Lue, Y., Lee, W. P., et al. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00124.2017 · Cited by 45
Ces3/TGH Deficiency Attenuates Steatohepatitis
Lian, J., Wei, E., Groenendyk, J., Das, S. K., Hermansson, M., Li, L., Watts, R., Thiesen, A., Oudit, G. Y., Michalak, M., et al. (2016) · Scientific Reports · doi:10.1038/srep25747 · Cited by 44
Lu, M. M., Patsouris, D., Li, P., Flores-Riveros, J. R., Frincke, J. M., Watkins, S. M., Schenk, S., & Olefsky, J. M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00668.2009 · Cited by 43
Banerjee, A., Das, D., Paul, R., Roy, S., Bhattacharjee, A., Prasad, S. K., Banerjee, O., Mukherjee, S., & Maji, B. K. (2020) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2019-0141 · Cited by 43
Sphingosine 1-phosphate metabolism and insulin signaling
Wigger, D., Schumacher, F., Schneider‐Schaulies, S., & Kleuser, B. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.109959 · Cited by 44
Dallak, M. A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.098 · Cited by 39
Kamath, S., Chávez, A. O., Gastaldelli, A., Casiraghi, F., Halff, G. A., ABRAHAMIAN, G. A., Davalli, A. M., Bastarrachea, R. A., Comuzzie, A. G., Guardado‐Mendoza, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027617 · Cited by 36
Self-citationPregnancy Toxemia in Ewes: A Review of Molecular Metabolic Mechanisms and Management Strategies
Ji, X., Liu, N., Wang, Y., Ding, K., Huang, S., & Zhang, C. (2023) · Metabolites · doi:10.3390/metabo13020149 · Cited by 44
Cai, Z., Jiang, X., Pan, Y., Chen, L., Zhang, L., Zhu, K., Cai, Y., Ling, Y., Chen, F., Xu, X., et al. (2015) · BMC Genomics · doi:10.1186/s12864-015-1283-0 · Cited by 35
Defining lipid mediators of insulin resistance: controversies and challenges
Metcalfe, L. K., Smith, G. C., & Turner, N. A. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0023 · Cited by 35
Arman, T., Lynch, K. D., Montonye, M. L., Goedken, M. J., & Clarke, J. (2019) · Toxins · doi:10.3390/toxins11070398 · Cited by 35
Buhl, E. S., Neschen, S., Yonemitsu, S., Rossbacher, J., Zhang, D., Morino, K., Flyvbjerg, A., Perret, P., Samuel, V. T., Kim, J., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00356.2007 · Cited by 34
Self-citationZhang, C., Cooper, D. E., Grevengoed, T. J., Li, L. O., Klett, E. L., Eaton, J. M., Harris, T. E., & Coleman, R. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00034.2014 · Cited by 34
Self-citationHammond, L. E., Albright, C. D., He, L., Rusyn, I., Watkins, S. M., Doughman, S. D., Lemasters, J. J., & Coleman, R. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.12.004 · Cited by 32
Self-citationCooper, D. E., Grevengoed, T. J., Klett, E. L., & Coleman, R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.649970 · Cited by 31
Self-citationEmerging therapies for metabolic diseases—the focus is on diabetes and obesity
Hughes, T. E. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.04.622 · Cited by 30
Alves‐Bezerra, M., Ramos, I., Paula, I. F. D., Maya‐Monteiro, C. M., Klett, E. L., Coleman, R., & Gondim, K. C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.12.004 · Cited by 28
Self-citationChen, C.-Y., Li, Y., Zeng, N., He, L., Zhang, X., Tu, T., Tang, Q., Alba, M. M., Mir, S., Stiles, E. X., et al. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.04.007 · Cited by 31
Self-citationAmerican College of Endocrinology Pre-Diabetes Consensus Conference: Part Two
Bloomgarden, Z. T. (2008) · Diabetes Care · doi:10.2337/dc08-zb11 · Cited by 26
Hou, G., Gao, Y. M., Poon, L. C., Ren, Y., Zeng, C., Wen, B., Syngelaki, A., Lin, L., Zi, J., Su, F., et al. (2022) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17297 · Cited by 27
Kawashima, Y., Chen, J., Sun, H., Lann, D. E., Hajjar, R. J., Yakar, S., & LeRoith, D. (2009) · Diabetologia · doi:10.1007/s00125-009-1378-8 · Cited by 27
Sakuma, I., Gaspar, R. C., Luukkonen, P. K., Kahn, M., Zhang, D., Zhang, X., Murray, S., Golla, J. P., Vatner, D. F., Samuel, V. T., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2312666120 · Cited by 25
Self-citationCollison, L. W., Murphy, E. J., & Jolly, C. A. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00371.2007 · Cited by 25
Choi, C. S., Ghoshal, P., Srinivasan, M., Kim, S., Cline, G. W., & Patel, M. S. (2010) · Lipids · doi:10.1007/s11745-010-3470-8 · Cited by 24
Self-citationEllis, J. M., Paul, D. S., DePetrillo, M. A., Singh, B. P., Malarkey, D. E., & Coleman, R. (2012) · Toxicologic Pathology · doi:10.1177/0192623311432298 · Cited by 24
Self-citationMosher, J., Zhang, W., Blumhagen, R. Z., D’Alessandro, A., Nemkov, T. G., Hansen, K. C., Hesselberth, J. R., & Reis, T. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.07.021 · Cited by 23
A Jak2 inhibitor, AG490, reverses lipin-1 suppression by TNF-α in 3T3-L1 adipocytes
Tsuchiya, Y., Takahashi, N., Yoshizaki, T., Tanno, S., Ohhira, M., Motomura, W., Tanno, S., Takakusaki, K., Kohgo, Y., & Okumura, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.021 · Cited by 23
Yazdi, M., Ahnmark, A., William‐Olsson, L., Snaith, M. R., Turner, N. A., Osla, F., Wedin, M., Asztély, A.-K., Elmgren, A., Bohlooly‐Y, M., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.156 · Cited by 23
Novel therapeutics and targets for the treatment of diabetes
Aicher, T. D., Boyd, S. A., McVean, M., & Celeste, A. J. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.1 · Cited by 21
Antu, K. A., Riya, M. P., Nair, A., Mishra, A., Srivastava, A. K., & Raghu, K. G. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.09.050 · Cited by 23
Badi, R. M., Mostafa, D. G., Khaleel, E. F., & Satti, H. H. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13074 · Cited by 22
Gauthier, M., Pérusse, J. R., Lavoie, M.-È., SLADEK, R. M., Madiraju, S. R. M., Ruderman, N. B., Coulombe, B., Prentki, M., & RABASA-LHORET, R. P. R. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1662 · Cited by 22
How Do I Fatten Thee? Let Me Count the Ways…
Coleman, R. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.004 · Cited by 21
Self-citationHakim, A., Moll, M. R., Brancale, J., Liu, J., Lasky-Su, J. A., Silverman, E. K., Vilarinho, S., Jiang, Z. G., Pita-Juárez, Y. H., Vlachos, I. S., et al. (2021) · Hepatology · doi:10.1002/hep.32038 · Cited by 19
Self-citation
Metadata
- Authors
- Neschen, S., Morino, K., Hammond, L. E., Zhang, D., Liu, Z.-X., Romanelli, A. J., Cline, G. W., Pongratz, R. L., Zhang, X.-M., Choi, C. S., Coleman, R. A., & Shulman, G. I.
- Affiliations
- Howard Hughes Medical Institute (US)
- University of North Carolina at Chapel Hill (US)
- Yale University (US)
- Corresponding author
- Shulman, Gerald I.
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 2
- Issue
- 1
- Pages
- 55-65
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2006375647
- Semantic Scholar
- e7251c54287df4fd1cb668ac0f825e2c909f61c2
- Cited by
- 261
- References
- 64
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 7 · 2023: 8 · 2022: 7 · 2021: 10 · 2020: 6 · 2019: 12 · 2018: 11 · 2017: 6 · 2016: 4 · 2015: 12 · 2014: 16 · 2013: 13 · 2012: 20
- FWCI
- 13.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (F31GM020920, F31 GM20920)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK40936, R01DK56598, U24DK59635, R01DK040936, U24DK059635, R01DK056598)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- hepatic steatosis, hepatic insulin resistance, knockout mice, high-fat diet, diacylglycerol, protein kinase C, triglycerides, insulin sensitivity, lipid metabolism
- MeSH terms
- Acetyl-CoA Carboxylase, Acetyl Coenzyme A, Animals, Dietary Fats, Diglycerides, Fasting, Fatty Liver, Glucose Tolerance Test, Glycerol-3-Phosphate O-Acyltransferase, Insulin Resistance, Liver, Lysophospholipids, Male, Malonyl Coenzyme A, Mice, Inbred C57BL, Mitochondria, Multienzyme Complexes, Phenotype, Triglycerides, Protein Serine-Threonine Kinases, Mice, Knockout, Mice, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
